P79701 AF NFT

Vascular endothelial growth factor receptor 3

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigbyay4zrzoddh4xr4bcc3xamdkok3qgkcd5w4fpc6sj4tvsrswny/metadata.json
IPFS of structure file: 
bafybeiexupdmjfatetef44vnmrnofla2fzgtdofxrip76ew3nnrgpw7rki/AF-P79701-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xD7A12721F841109403a67A62cb1740320d8999f8
First NFT owner address (bech32): 
genesis167sjwg0cgygfgqax0f3vk96qxgxcnx0ceqdexf
Current NFT ID #496219 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
496219
Accession (UniProt):
P79701
Name::
Vascular endothelial growth factor receptor 3
Experimental Method:
Predicted structure
Sequence source:
COTURNIX COTURNIX

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P79701 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P79701|VGFR3_COTCO Vascular endothelial growth factor receptor 3 OS=Coturnix coturnix OX=9091 GN=FLT4 PE=2 SV=1 MKRVCTLPLWLWLGIVSEADLVSSYSMTPPTLSITEEEHIINAKDTLTITCRGQHPLEWSWPGARWTPVEGRRRWNSQPQQRPVGAGNPEEDCEGTGTKPYCKVLVLTESQANDTGYYHCYYKYIDAKIEGTTAVSAYIFVRDFEQPFINKPETLLISKKENTWVPCLVSIPDLNVTLISQNSLIHPDRKTIFWDNKKGMQVPTQLIRDSLFVQCETVIDNKVFKSNFFIIHIAGIELYDIQLYPKKAMELLVGEKLVLNCTVWAEFNSGVRFQWTYPGKQMQRAVIESERRSLQTHTELSSILTLHNVSQQDLGRYTCTATNGAQMLEESTDVIVHEKPFINVEWRKGPVIEATAGDEAVKLPVKVVAYPQPDFQWYKAGKLIPKQSQSSMQIKDVAEHHAGTYTLVLRNRLVGLEKRISLQLIVNVPPRIHEKETSSPSIYSRRSPQALTCTVYGIPAPEVIQWQWRPWMPCRMFSRRSLNSRHRAARRHQRDRMPECKDWKDVSRQDAVNPIESIDTWVEFVEGRNKTVSKLAIQEANVSAMYKCIASNKVGRDERLIYFYVTTIPDGFEIESQPSEEPIEGQDLQLSCNADNYTYENLQWYRLNLSKLHDEEGNPLVLDCKNVHHYATKMQGELRFQPDSNDATLLLTIPNISLGEEGDYVCEVQNRKTREKHCHKKYISVQALEIPRLKQNLTDIWVNVSDSIEMRCKVDGNHVPDISWYKDEKLVEEVSGIDLADFNQRLSIQRVREEDAGLYLCSVCNAKGCVNSSASVSVEGSDDKTNVEIVILIGTGVIAVFFWILLIIIFCNIKRPAHADIKTGYLSIIMDPGEVPLEEQCAYLPYDSSKWEFPRDRLRLGKVLGHGAFGKVVEASAFGINKSNSCETVAAKMLKEGATASEQKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNYLRTKREGFSPYREKSPRLRIQVQSIVEAVRADRRSRSGTSDSAIFNRFLMHKSQTVQPIQEVDDLWQSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRFKDGTRMRAPEYTTAEIYRIMLSCWHGDPKERPTFSDLVEILGNLLQENVQQEGKDYIPLNDSHSSEDDGFSQVPSSAQQNSDEEDFDMRIRCHSLAARYYNCVSFPGCLTGGNQIRCSSRIKTFEEFPMTHTMYKAHPDNQTDSGMVLASEEFERIENRHRKEGGFSSKGPNRTAELSAEQSDLRGRCRPSYGSQVGGQTFYNSEYGELSEHSEDRSCTPPAEGASPPALHASFFSEQY